Skip to content

Knowledge Center

News

Resonetics Announces Recapitalization with GTCR’s Regatta Medical

Regatta Medical to Support Growth of Market-Leader in Micromanufacturing for the Life Sciences

Resonetics announced today that Regatta Medical has made a strategic investment in Resonetics. Led by CEO Chip Hance, Regatta Medical is a portfolio company of GTCR, a leading private equity investor in the healthcare sector. Going forward, the existing Resonetics management team, led by CEO Tom Burns, will continue in their existing roles as a subsidiary of Regatta Medical.

Follow to Read the Full Release

whitepapers
Nitinol Post-Shape-Setting TTT & TTS Properties
news
Resonetics® Invests in Nitinol Gun Drilling Capabilities Through Purchase of Assets from Medical Component Specialists
news
Resonetics Announces Nitinol Tubing Capability and Capacity Investments in Bethel, CT Facility
news
Scott Robertson Joins SMST Board: Advancing Shape Memory and Superelastic Technologies
0